{
  "title": "Accelerating drug target inhibitor discovery with a deep generative foundation model",
  "url": "https://openalex.org/W4381547631",
  "year": 2023,
  "authors": [
    {
      "id": "https://openalex.org/A2221080166",
      "name": "Vijil Chenthamarakshan",
      "affiliations": [
        "IBM Research - Thomas J. Watson Research Center"
      ]
    },
    {
      "id": "https://openalex.org/A2804104711",
      "name": "Samuel C. Hoffman",
      "affiliations": [
        "IBM Research - Thomas J. Watson Research Center"
      ]
    },
    {
      "id": "https://openalex.org/A2255311852",
      "name": "C David Owen",
      "affiliations": [
        "Diamond Light Source",
        "Research Complex at Harwell"
      ]
    },
    {
      "id": "https://openalex.org/A3105798041",
      "name": "Petra Lukacik",
      "affiliations": [
        "Diamond Light Source",
        "Research Complex at Harwell"
      ]
    },
    {
      "id": "https://openalex.org/A4211822184",
      "name": "Claire Strain-Damerell",
      "affiliations": [
        "Research Complex at Harwell",
        "Diamond Light Source"
      ]
    },
    {
      "id": "https://openalex.org/A2801479758",
      "name": "Daren Fearon",
      "affiliations": [
        "Research Complex at Harwell",
        "Diamond Light Source"
      ]
    },
    {
      "id": "https://openalex.org/A2906113937",
      "name": "Tika R. Malla",
      "affiliations": [
        "University of Oxford"
      ]
    },
    {
      "id": "https://openalex.org/A2175650361",
      "name": "Anthony Tumber",
      "affiliations": [
        "University of Oxford"
      ]
    },
    {
      "id": "https://openalex.org/A2104627187",
      "name": "Christopher J Schofield",
      "affiliations": [
        "University of Oxford"
      ]
    },
    {
      "id": "https://openalex.org/A3123957089",
      "name": "Helen M. E. Duyvesteyn",
      "affiliations": [
        "Centre for Human Genetics",
        "University of Oxford"
      ]
    },
    {
      "id": "https://openalex.org/A766374820",
      "name": "Wanwisa Dejnirattisai",
      "affiliations": [
        "University of Oxford",
        "Centre for Human Genetics"
      ]
    },
    {
      "id": "https://openalex.org/A2763027930",
      "name": "Loic Carrique",
      "affiliations": [
        "Centre for Human Genetics",
        "University of Oxford"
      ]
    },
    {
      "id": "https://openalex.org/A2131962161",
      "name": "Thomas S. Walter",
      "affiliations": [
        "Centre for Human Genetics",
        "University of Oxford"
      ]
    },
    {
      "id": "https://openalex.org/A1919882831",
      "name": "Gavin R. Screaton",
      "affiliations": [
        "University of Oxford",
        "Centre for Human Genetics"
      ]
    },
    {
      "id": "https://openalex.org/A1926978523",
      "name": "Tetiana Matviiuk",
      "affiliations": [
        "Enamine (Ukraine)"
      ]
    },
    {
      "id": "https://openalex.org/A2116316968",
      "name": "Aleksandra Mojsilovic",
      "affiliations": [
        "IBM Research - Thomas J. Watson Research Center"
      ]
    },
    {
      "id": "https://openalex.org/A2007008578",
      "name": "Jason Crain",
      "affiliations": [
        "University of Oxford"
      ]
    },
    {
      "id": "https://openalex.org/A2683288892",
      "name": "Martin A. Walsh",
      "affiliations": [
        "Diamond Light Source",
        "Research Complex at Harwell"
      ]
    },
    {
      "id": "https://openalex.org/A2666580907",
      "name": "David I Stuart",
      "affiliations": [
        "Diamond Light Source",
        "Centre for Human Genetics",
        "University of Oxford"
      ]
    },
    {
      "id": "https://openalex.org/A2211214061",
      "name": "Payel Das",
      "affiliations": [
        "IBM Research - Thomas J. Watson Research Center"
      ]
    }
  ],
  "references": [
    "https://openalex.org/W3026310980",
    "https://openalex.org/W2023818227",
    "https://openalex.org/W2273267066",
    "https://openalex.org/W2794979247",
    "https://openalex.org/W3209416355",
    "https://openalex.org/W2971690404",
    "https://openalex.org/W2784270883",
    "https://openalex.org/W3127493072",
    "https://openalex.org/W1975147762",
    "https://openalex.org/W2980789587",
    "https://openalex.org/W3027325047",
    "https://openalex.org/W3010145447",
    "https://openalex.org/W3087409770",
    "https://openalex.org/W3048700434",
    "https://openalex.org/W4213043615",
    "https://openalex.org/W4310088512",
    "https://openalex.org/W4285086879",
    "https://openalex.org/W3143973178",
    "https://openalex.org/W3112470441",
    "https://openalex.org/W3122825960",
    "https://openalex.org/W3159141234",
    "https://openalex.org/W3193127957",
    "https://openalex.org/W3130155181",
    "https://openalex.org/W4313703391",
    "https://openalex.org/W3015608194",
    "https://openalex.org/W4220976155",
    "https://openalex.org/W3195580817",
    "https://openalex.org/W1988037271",
    "https://openalex.org/W2593436234",
    "https://openalex.org/W3096418018",
    "https://openalex.org/W4211218744",
    "https://openalex.org/W4210339673",
    "https://openalex.org/W4313880353",
    "https://openalex.org/W3186179742",
    "https://openalex.org/W2897337442",
    "https://openalex.org/W2891868449",
    "https://openalex.org/W2793945656",
    "https://openalex.org/W3042210295",
    "https://openalex.org/W3011004456",
    "https://openalex.org/W3146944767",
    "https://openalex.org/W4206153788",
    "https://openalex.org/W3201249640",
    "https://openalex.org/W3166941484",
    "https://openalex.org/W4313485929",
    "https://openalex.org/W2963223306",
    "https://openalex.org/W2176516200",
    "https://openalex.org/W2529996553",
    "https://openalex.org/W2204695023",
    "https://openalex.org/W2809216727",
    "https://openalex.org/W2276859037",
    "https://openalex.org/W2594183968",
    "https://openalex.org/W2134967712",
    "https://openalex.org/W3083406432",
    "https://openalex.org/W2074473216",
    "https://openalex.org/W1975738348",
    "https://openalex.org/W2420659973",
    "https://openalex.org/W2152602391",
    "https://openalex.org/W3092125766",
    "https://openalex.org/W3007643904",
    "https://openalex.org/W3167237074",
    "https://openalex.org/W2590738066",
    "https://openalex.org/W2108921801",
    "https://openalex.org/W2604418577",
    "https://openalex.org/W2124026197",
    "https://openalex.org/W2585341756",
    "https://openalex.org/W4245395188",
    "https://openalex.org/W2038840577",
    "https://openalex.org/W3104727101",
    "https://openalex.org/W4212952700",
    "https://openalex.org/W3169782252",
    "https://openalex.org/W1981737096",
    "https://openalex.org/W2052907531",
    "https://openalex.org/W2105649494",
    "https://openalex.org/W2011505858",
    "https://openalex.org/W2003076573",
    "https://openalex.org/W2039478311",
    "https://openalex.org/W2043509228",
    "https://openalex.org/W2113364934",
    "https://openalex.org/W2042338355",
    "https://openalex.org/W2578240541",
    "https://openalex.org/W2567534979",
    "https://openalex.org/W2991736596",
    "https://openalex.org/W3116865743",
    "https://openalex.org/W3098269892",
    "https://openalex.org/W3135156311",
    "https://openalex.org/W4210309881"
  ],
  "abstract": "Inhibitor discovery for emerging drug-target proteins is challenging, especially when target structure or active molecules are unknown. Here, we experimentally validate the broad utility of a deep generative framework trained at-scale on protein sequences, small molecules, and their mutual interactionsâ€”unbiased toward any specific target. We performed a protein sequence-conditioned sampling on the generative foundation model to design small-molecule inhibitors for two dissimilar targets: the spike protein receptor-binding domain (RBD) and the main protease from SARS-CoV-2. Despite using only the target sequence information during the model inference, micromolar-level inhibition was observed in vitro for two candidates out of four synthesized for each target. The most potent spike RBD inhibitor exhibited activity against several variants in live virus neutralization assays. These results establish that a single, broadly deployable generative foundation model for accelerated inhibitor discovery is effective and efficient, even in the absence of target structure or binder information.",
  "full_text": null,
  "topic": "Drug discovery",
  "concepts": [
    {
      "name": "Drug discovery",
      "score": 0.7950177788734436
    },
    {
      "name": "Computational biology",
      "score": 0.7099276781082153
    },
    {
      "name": "Generative grammar",
      "score": 0.5728278160095215
    },
    {
      "name": "Protease inhibitor (pharmacology)",
      "score": 0.5455959439277649
    },
    {
      "name": "Generative model",
      "score": 0.5395026206970215
    },
    {
      "name": "Sequence (biology)",
      "score": 0.48926207423210144
    },
    {
      "name": "Inference",
      "score": 0.4468030333518982
    },
    {
      "name": "Small molecule",
      "score": 0.44280827045440674
    },
    {
      "name": "Computer science",
      "score": 0.4065644443035126
    },
    {
      "name": "Biology",
      "score": 0.39800649881362915
    },
    {
      "name": "Artificial intelligence",
      "score": 0.35107898712158203
    },
    {
      "name": "Bioinformatics",
      "score": 0.26367050409317017
    },
    {
      "name": "Virus",
      "score": 0.22393029928207397
    },
    {
      "name": "Virology",
      "score": 0.18949046730995178
    },
    {
      "name": "Biochemistry",
      "score": 0.1825910210609436
    },
    {
      "name": "Viral load",
      "score": 0.0
    },
    {
      "name": "Antiretroviral therapy",
      "score": 0.0
    }
  ]
}